PRISM BioLab Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
35
- Stock Symbol
-
206A
- Share Price
-
$0.53
- (As of Thursday Closing)
PRISM BioLab General Information
Description
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.
Contact Information
Website
www.prismbiolab.comCorporate Office
- 2-26-1, Muraoka-Higashi
- Shonan Eye Park
- Fujisawa, Kanagawa 251-8555
- Japan
Corporate Office
- 2-26-1, Muraoka-Higashi
- Shonan Eye Park
- Fujisawa, Kanagawa 251-8555
- Japan
PRISM BioLab Stock Performance
As of 19-Nov-2026, PRISM BioLab’s stock price is $0.53. Its current market cap is $19.7M with 37M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.53 | $0.55 | $0.51 - $1.79 | $19.7M | 37M | 132K | -$0.15 |
PRISM BioLab Financials Summary
As of 30-Jun-2026, PRISM BioLab has a trailing 12-month revenue of $4.77M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 30-Sep-2025 | FY 2024 30-Sep-2024 | FY 2023 30-Sep-2023 |
|---|---|---|---|---|
| EV | 17,713 | 19,226 | 79,995 | |
| Revenue | 4,775 | 4,539 | 2,033 | 813 |
| EBITDA | (3,722) | |||
| Net Income | (5,669) | (5,587) | (6,983) | (3,793) |
| Total Assets | 15,279 | 20,764 | 31,709 | 8,110 |
| Total Debt | 0 | 0 | 0 | 0 |
PRISM BioLab Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PRISM BioLab Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
PRISM BioLab Comparisons
Industry
Financing
Details
PRISM BioLab Competitors (4)
One of PRISM BioLab’s 4 competitors is PeptiDream, a Formerly VC-backed company based in Kawasaki, Japan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| PeptiDream | Formerly VC-backed | Kawasaki, Japan | ||||
| Ipsen | Formerly PE-Backed | Paris, France | ||||
| Protagonist Therapeutics | Formerly VC-backed | Newark, CA | ||||
| Ayala Pharmaceuticals | Corporation | Wilmington, DE |
PRISM BioLab Patents
PRISM BioLab Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2025512138-A | New seven-membered ring fused compound | Pending | 11-Apr-2022 | ||
| EP-4508052-A1 | Novel seven-membered ring-fused compounds | Pending | 11-Apr-2022 | ||
| EP-4508052-A4 | Novel seven-membered ring-fused compounds | Pending | 11-Apr-2022 | ||
| US-20250250282-A1 | Novel seven-membered ring-fused compounds | Pending | 11-Apr-2022 | ||
| WO-2023200017-A1 | Novel seven-membered ring-fused compounds | Inactive | 11-Apr-2022 | C07D495/14 |
PRISM BioLab Signals
PRISM BioLab Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
PRISM BioLab ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
PRISM BioLab FAQs
-
When was PRISM BioLab founded?
PRISM BioLab was founded in 2006.
-
Where is PRISM BioLab headquartered?
PRISM BioLab is headquartered in Fujisawa, Japan.
-
What is the size of PRISM BioLab?
PRISM BioLab has 35 total employees.
-
What industry is PRISM BioLab in?
PRISM BioLab’s primary industry is Drug Discovery.
-
Is PRISM BioLab a private or public company?
PRISM BioLab is a Public company.
-
What is PRISM BioLab’s stock symbol?
The ticker symbol for PRISM BioLab is 206A.
-
What is the current stock price of PRISM BioLab?
As of 19-Nov-2026 the stock price of PRISM BioLab is $0.53.
-
What is the current market cap of PRISM BioLab?
The current market capitalization of PRISM BioLab is $19.7M.
-
What is PRISM BioLab’s current revenue?
The trailing twelve month revenue for PRISM BioLab is $4.77M.
-
Who are PRISM BioLab’s competitors?
PeptiDream, Ipsen, Protagonist Therapeutics, and Ayala Pharmaceuticals are competitors of PRISM BioLab.
-
What is PRISM BioLab’s annual earnings per share (EPS)?
PRISM BioLab’s EPS for 12 months was -$0.15.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process